PreprintAll rights reservedbioRxiv
The anti-dyskinetic and the anti-parkinsonian effects of sub-anesthetic ketamine are also present in female preclinical models
- 1The University of Arizona
Related
- Neuroprotective activity of sub-anesthetic ketamine in a preclinical model of Parkinson's disease is not blocked by antagonizing brain-derived neurotrophic factor signaling
- Dyskinesia induced by a dopamine 2 receptor-like agonist, but not a dopamine 1 receptor-like agonist, is blocked by sub-anesthetic ketamine
- Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys
- L-DOPA Rescues Reach Height but Not Trajectory Area in a Bimanual String-Pulling Behavior in Parkinsonian Rats
- Parkinsonian syndromes in institutionalized older adults in the French Caribbean: Clinical characteristics and one-year mortality
BibTeX
@misc{parmar2026antidyskinetic,
title = {{The anti-dyskinetic and the anti-parkinsonian effects of sub-anesthetic ketamine are also present in female preclinical models}},
author = {R. Parmar and M. J. Bartlett and J. R. Meredith and S. Singh and S. Ragsdale and S. J. Sherman and T. Falk},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.27.762342},
url = {https://www.biorxiv.org/content/10.64898/2026.10.27.762342v1},
}
RIS
TY - UNPB
TI - The anti-dyskinetic and the anti-parkinsonian effects of sub-anesthetic ketamine are also present in female preclinical models
AU - R. Parmar
AU - M. J. Bartlett
AU - J. R. Meredith
AU - S. Singh
AU - S. Ragsdale
AU - S. J. Sherman
AU - T. Falk
PY - 2026
DA - 2026/10/27
PB - bioRxiv
DO - 10.64898/2026.10.27.762342
UR - https://www.biorxiv.org/content/10.64898/2026.10.27.762342v1
ER -